erlotinib hydrochloride has been researched along with Injuries, Spinal Cord in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, MB; Kjell, J; Olson, L; Pernold, K | 1 |
| Miller, G | 1 |
2 other study(ies) available for erlotinib hydrochloride and Injuries, Spinal Cord
| Article | Year |
|---|---|
Oral erlotinib, but not rapamycin, causes modest acceleration of bladder and hindlimb recovery from spinal cord injury in rats.
Topics: Administration, Oral; Animals; Disease Models, Animal; Erlotinib Hydrochloride; Female; Hindlimb; Immunosuppressive Agents; Locomotion; Protein Kinase Inhibitors; Quinazolines; Rats, Sprague-Dawley; Recovery of Function; Sirolimus; Spinal Cord Injuries; Urinary Bladder | 2014 |
Neuroscience. Cancer drugs may help injured nerve cells regrow their axons.
Topics: Animals; Antineoplastic Agents; Axons; Cells, Cultured; ErbB Receptors; Erlotinib Hydrochloride; Mice; Nerve Crush; Nerve Regeneration; Neurons; Optic Nerve Injuries; Quinazolines; Rats; Signal Transduction; Spinal Cord Injuries | 2005 |